Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter,Randomized Controlled Trial Towards Identifying the Optimal GnRH Antagonist Treatment Protocol

NCT00866034 is registered in ClinicalTrials.gov with Bart CJM Fauser as lead sponsor.

NCT NCT00866034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00866034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter,Randomized Controlled Trial Towards Identifying the Optimal GnRH Antagonist Treatment Protocol
Lead sponsor
Bart CJM Fauser
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2009
Completion date
October 31, 2012
Enrollment
617 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

in vitro fertilization, intracytoplasmic sperm injection